RARE·90400D108·US·equity·Healthcare - Biotechnology-13D/G
RARE (ULTRAGENYX PHARMACEUTICAL IN) is held by 152 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($152.9M), STATE STREET CORP ($105.2M), AQR CAPITAL MANAGEMENT LLC ($95.9M). Net institutional sentiment: Mixed.
See how RARE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer